Immune mechanisms in epileptogenesis

Frontiers in Cellular Neuroscience

Volumn 7, Issue NOV, 2013, Pages

  Xu, Dan ^a,b   Miller, Stephen D ^a   Koh, Sookyong ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Astrocytes; Epilepsy; Epileptogenesis; Immune response; Inflammation; Microglia; Seizure; T lymphocytes

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CORTICOTROPIN; CYCLOOXYGENASE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GLUTAMATE RECEPTOR 3; GLYCINE RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NATALIZUMAB; PADGEM PROTEIN; PROSTAGLANDIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; VOLTAGE GATED CALCIUM CHANNEL;

ADAPTIVE IMMUNITY; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN INJURY; CEREBROSPINAL FLUID; CLINICAL TRIAL (TOPIC); ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HASHIMOTO ENCEPHALOPATHY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE; MICROGLIA; NERVE EXCITABILITY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; SYNAPTIC TRANSMISSION; T LYMPHOCYTE; TH1 TH2 BALANCE;

EID: 84888314495     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00195     Document Type: Review

References (113)

1. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640. doi: 10.1038/ nri1664
2. Armangue, T., Petit-Pedrol, M., and Dalmau, J. (2012). Autoimmune encephalitis in children. J. Child Neurol. 27, 1460-1469. doi: 10.1177/0883073812448838
3. Armangue, T., Titulaer, M. J., Malaga, I., Bataller, L., Gabilondo, I., Graus, F., et al. (2013). Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J. Pediatr. 162, 850-856. doi: 10.1016/j.jpeds.2012.10.011
4. Aronica, E., Boer, K., van Vliet, E. A., Redeker, S., Baayen, J. C., Spliet, W. G., et al. (2007). Complement activation in experimental and human temporal lobe epilepsy. Neurobiol. Dis. 26, 497-511. doi: 10.1016/j.nbd.2007.01.015
5. Aronica, E., and Gorter, J. A. (2007). Gene expression profile in temporal lobe epilepsy. Neuroscientist 13, 100-108. doi: 10.1177/1073858406295832
6. Baik, E. J., Kim, E. J., Lee, S. H., and Moon, C. (1999). Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res. 843, 118-129. doi: 10.1016/S0006-8993(99)01797-7
7. Ban, E., Milon, G., Prudhomme, N., Fillion, G., and Haour, F. (1991). Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43, 21-30. doi: 10.1016/0306-4522(91)90412-H
8. Banks, W. A., and Erickson, M. A. (2010). The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 37, 26-32. doi: 10.1016/j.nbd.2009.07.031
9. Baram, T. Z., Mitchell, W. G., Tournay, A., Snead, O. C., Hanson, R. A., and Horton, E. J. (1996). High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 97, 375-379.
10. Bauer, J., Elger, C. E., Hans, V. H., Schramm, J., Urbach, H., Lassmann, H., et al. (2007). Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann. Neurol. 62, 67-80. doi: 10.1002/ana.21148
11. Bell, M. D., and Perry, V. H. (1995). Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 24, 695-710. doi:10.1007/BF01179819
12. Bellinger, F. P., Madamba, S., and Siggins, G. R. (1993). Interleukin 1 beta inhibits synaptic strength and longterm potentiation in the rat CA1 hippocampus. Brain Res. 628, 227-234. doi: 10.1016/0006-8993(93)90959-Q
13. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., et al. (2001). CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710. doi: 10.1038/89490
14. Bien, C. G., Urbach, H., Schramm, J., Soeder, B. M., Becker, A. J., Voltz, R., et al. (2007). Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69, 1236-1244. doi: 10.1212/01.wnl.0000276946.08412.ef
15. Boer, K., Jansen, F., Nellist, M., Redeker, S., van den Ouweland, A. M., Spliet, W. G., et al. (2008). Aronica, Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 78, 7-21. doi: 10.1016/j.eplepsyres.2007.10.002
16. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., et al. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 90, 10061-10065. doi: 10.1073/pnas.90.21.10061
17. Castillo, P., Woodruff, B., Caselli, R., Vernino, S., Lucchinetti, C., Swanson, J., et al. (2006). Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch. Neurol. 63, 197-202. doi: 10.1001/archneur.63.2.197
18. Chakravarty, S., and Herkenham, M. (2005). Toll-like receptor 4 on non-hematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J. Neurosci. 25, 1788-1796. doi: 10.1523/JNEUROSCI.4268-04.2005
19. Chiu, S. S., Tse, C. Y., Lau, Y. L., and Peiris, M. (2001). Influenza A infection is an important cause of febrile seizures. Pediatrics 108, E63. doi: 10.1542/peds.108.4.e63
20. Choi, J., Nordli, D. R. Jr., Alden, T. D., DiPatri, A. Jr., Laux, L., Kelley, K., et al. (2009). Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J. Neuroinflammation 6, 38. doi: 10.1186/1742-2094-6-38
21. Cutler, R. W., Watters, G. V., and Hammerstad, J. P. (1970). The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man. J. Neurol. Sci. 10, 259-268. doi: 10.1016/0022-510X(70)90154-1
22. Dalakas, M. C. (1998). Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51, S2-S8. doi: 10.1212/WNL.51.6_Suppl_5.S2
23. Dalmau, J. (2009). Status epilepticus due to paraneoplastic and nonparaneoplastic encephalitides. Epilepsia 50(Suppl. 12), S58-S60. doi: 10.1111/j.1528-1167.2009.02352.x
24. Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., et al. (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 7, 1091-1098. doi: 10.1016/S1474-4422(08)70224-2
25. Dalmau, J., and Rosenfeld, M. R. (2008). Paraneoplastic syndromes of the CNS. Lancet Neurol. 7, 327-340. doi: 10.1016/S1474-4422(08) 70060-7
26. De Simoni, M. G., Perego, C., Ravizza, T., Moneta, D., Conti, M., Marchesi, F., et al. (2000). Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 12, 2623-2633. doi: 10.1046/j.1460-9568. 2000.00140.x
27. Devinsky, O. (2004). Effects of seizures on autonomic and cardiovascular function. Epilepsy Curr. 4, 43-46. doi: 10.1111/j.1535-7597.2004.42001.x
28. Dhote, F., Peinnequin, A., Carpentier, P., Baille, V., Delacour, C., Foquin, A., et al. (2007). Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 238, 166-176. doi: 10.1016/j.tox.2007.05.032
29. Donat, J. F. (1992). The age-dependent epileptic encephalopathies. J. Child Neurol. 7, 7-21. doi: 10.1177/088307389200700102
30. Dube, C., Vezzani, A., Behrens, M., Bartfai, T., and Baram, T. Z. (2005). Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 57, 152-155. doi: 10.1002/ana.20358
31. Eibl, M. M., and Wedgwood, R. J. (1989). Intravenous immunoglobulin: a review. Immunodefic. Rev. 1(Suppl.), S1-S42.
32. Engel, J. Jr. (2001). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42, 796-803. doi: 10.1046/j.15281157.2001.10401.x
33. Ericsson, A., Liu, C., Hart, R. P., and Sawchenko, P. E. (1995). Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361, 681-698. doi: 10.1002/cne.903610410
34. Eriksson, C., Tehranian, R., Iverfeldt, K., Winblad, B., and Schultzberg, M. (2000). Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. J. Neurosci. Res. 60, 266-279. doi: 10.1002/(SICI)10974547(20000415)60:2<266::AID-JN R16>3.0.CO;2-P
35. Fabene, P. F., Laudanna, C., and Constantin, G. (2013). Leukocyte trafficking mechanisms in epilepsy. Mol. Immunol. 55, 100-104. doi: 10.1016/j.molimm.2012.12.009
36. Fabene, P. F., Navarro Mora, G., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., et al. (2008). A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377-1383. doi: 10.1038/nm.1878
37. Ferguson, A. R., Christensen, R. N., Gensel, J. C., Miller, B. A., Sun, F., Beattie, E. C., et al. (2008). Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 28, 11391-11400. doi: 10.1523/JNEUROSCI.3708-08. 2008
38. Friedman, A., Kaufer, D., and Heinemann, U. (2009). Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 85, 142-149. doi: 10.1016/j.eplepsyres.2009.03.005
39. Gorter, J. A., van Vliet, E. A., Aronica, E., Breit, T., Rauwerda, H., and Lopes da Silva, F. H. (2006). Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 26, 11083-11110. doi: 10.1523/JNEUROSCI.2766-06.2006
40. Greenwood, J., Etienne-Manneville, S., Adamson, P., and Couraud, P. O. (2002). Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol. 38, 315-322. doi: 10.1016/S15371891(02)00199-4
41. Hall, C. B., Long, C. E., Schnabel, K. C., Caserta, M. T., McIntyre, K. M., Costanzo, M. A., et al. (1994). Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med. 331, 432-438. doi: 10.1056/NEJM199408183310703
42. Hart, Y. M., Cortez, M., Andermann, F., Hwang, P., Fish, D. R., Dulac, O., et al. (1994). Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 44, 1030-1036. doi:10.1212/WNL.44.6.1030
43. He, X. P., Patel, M., Whitney, K. D., Janumpalli, S., Tenner, A., and McNamara, J. O. (1998). Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 20, 153-163. doi: 10.1016/S0896-6273(00) 80443-2
44. Holtman, L., van Vliet, E. A., Edelbroek, P. M., Aronica, E., and Gorter, J. A. (2010). Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Res. 91, 49-56. doi: 10.1016/j.eplepsyres.2010.06.011
45. Hrachovy, R. A., Frost, J. D. Jr., Kellaway, P., and Zion, T. E. (1983). Double-blind study of ACTH vs prednisone therapy in infantile spasms. J. Pediatr. 103, 641-645. doi: 10.1016/S00223476(83)80606-4
46. Hu, S., Sheng, W. S., Ehrlich, L. C., Peterson, P. K., and Chao, C. C. (2000). Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7, 153-159. doi: 10.1159/000026433
47. Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., et al. (2007). TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130, 535-547. doi: 10.1093/brain/awl317
48. Jones, J. E., Austin, J. K., Caplan, R., Dunn, D., Plioplys, S., and Salpekar, J. A. (2008). Psychiatric disorders in children and adolescents who have epilepsy. Pediatr. Rev. 29, e9-e14. doi: 10.1542/pir.29-2-e9
49. Jung, K. H., Chu, K., Lee, S. T., Kim, J., Sinn, D. I., Kim, J. M., et al. (2006). Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis. 23, 237-246. doi: 10.1016/j.nbd.2006.02.016
50. Kanemoto, K., Kawasaki, J., Yuasa, S., Kumaki, T., Tomohiro, O., Kaji, R., et al. (2003). Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 44, 796-799. doi: 10.1046/j.15281157.2003.43302.x
51. Kawada, J., Kimura, H., Ito, Y., Hara, S., Iriyama, M., Yoshikawa, T., et al. (2003). Systemic cytokine responses in patients with influenza-associated encephalopathy. J. Infect. Dis. 188, 690-698. doi: 10.1086/377101
52. Kivity, S., Lerman, P., Ariel, R., Danziger, Y., Mimouni, M., and Shinnar, S. (2004). Long-term cognitive out-comes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 45, 255-262. doi: 10.1111/j.0013-9580.2004.30503.x
53. Kondo, K., Nagafuji, H., Hata, A., Tomomori, C., and Yamanishi, K. (1993). Association of human her-pesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J. Infect. Dis. 167, 1197-1200. doi: 10.1093/infdis/167. 5.1197
54. Kulkarni, S. K., and Dhir, A. (2009). Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc.) 45, 135-154. doi: 10.1358/dot.2009.45.2.1322481
55. Lee, B., Dziema, H., Lee, K. H., Choi, Y. S., and Obrietan, K. (2007). CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus. Neurobiol. Dis. 25, 80-91. doi: 10.1016/j.nbd.2006.08.015
56. Ley, K., Laudanna, C., Cybulsky, M. I., and Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689. doi: 10.1038/nri2156
57. Librizzi, L., Ravizza, T., Vezzani, A., and de Curtis, M. (2010). Expression of IL-1 beta induced by epileptiform activity in the isolated guinea pig brain in vitro. Epilepsia 51(Suppl. 4), 18.
58. Librizzi, L., Regondi, M. C., Pastori, C., Frigerio, S., Frassoni, C., and de Curtis, M. (2007). Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 48, 743-751. doi: 10.1111/j.1528-1167.2007.01047.x
59. Mackay, M. T., Weiss, S. K., Adams-Webber, T., Ashwal, S., Stephens, D., Ballaban-Gill, K., et al. (2004). Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 62, 1668-1681. doi: 10. 1212/01.WNL.0000127773.72699.C8
60. Mantegazza, R., Bernasconi, P., Baggi, F., Spreafico, R., Ragona, F., Antozzi, C., et al. (2002). Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol. 131, 179-185. doi: 10.1016/S0165-5728(02)00261-8
61. Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., et al. (2010). Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 16, 413-419. doi: 10.1038/nm.2127
62. Masuyama, T., Matsuo, M., Ichimaru, T., Ishii, K., Tsuchiya, K., and Hamasaki, Y. (2002). Possible contribution of interferon-alpha to febrile seizures in influenza. Pediatr. Neurol. 27, 289-292. doi: 10.1016/S08878994(02)00452-6
63. Millichap, J. G. (1959). Studies in febrile seizures I Height of body temperature as a measure of the febrile-seizure threshold. Pediatrics 23, 76-85.
64. Minami, M., Kuraishi, Y., and Satoh, M. (1991). Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176, 593-598. doi: 10.1016/S0006291X(05)80225-6
65. Oby, E., and Janigro, D. (2006). The blood-brain barrier and epilepsy. Epilepsia 47, 1761-1774. doi: 10.1111/j.1528-1167.2006.00817.x
66. Pellock, J. M. (2004). Understanding co-morbidities affecting children with epilepsy. Neurology 62, S17-S23. doi: 10.1212/WNL.62.5_suppl_2.S17
67. Peltier, D. C., Simms, A., Farmer, J. R., and Miller, D. J. (2010). Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J. Immunol. 184, 7010-7021. doi: 10.4049/jimmunol.0904133
68. Plata-Salaman, C. R., and Ffrench-Mullen, J. M. (1994). Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur. J. Pharmacol. 266, 1-10. doi: 10.1016/0922-4106(94)90202-X
69. Polascheck, N., Bankstahl, M., and Loscher, W. (2010). The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol. 224, 219-233. doi: 10.1016/j.expneurol.2010.03.014
70. Probert, L., Akassoglou, K., Kassiotis, G., Pasparakis, M., Alexopoulou, L., and Kollias, G. (1997). TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72, 137-141. doi: 10.1016/S0165-5728 (96)00184-1
71. Ransohoff, R. M., Kivisakk, P., and Kidd, G. (2003). Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581. doi: 10.1038/nri1130
72. Ravizza, T., Gagliardi, B., Noe, F., Boer, K., Aronica, E., and Vezzani, A. (2008). Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29, 142-160. doi: 10.1016/j.nbd.2007.08.012
73. Ravizza, T., and Vezzani, A. (2006). Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience 137, 301-308. doi: 10.1016/j.neuroscience.2005.07.063
74. Riazi, K., Galic, M. A., and Pittman, Q. J. (2010). Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 89, 34-42. doi: 10.1016/j.eplepsyres.2009.09.004
75. Rodgers, K. M., Hutchinson, M. R., Northcutt, A., Maier, S. F., Watkins, L. R., and Barth, D. S. (2009). The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 132, 2478-2486. doi: 10.1093/brain/awp177
76. Rogers, S. W., Andrews, P. I., Gahring, L. C., Whisenand, T., Cauley, K., Crain, B., et al. (1994). Autoanti-bodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265, 648-651. doi: 10.1126/science.8036512
77. Rozovsky, I., Morgan, T. E., Willoughby, D. A., Dugichi-Djordjevich, M. M., Pasinetti, G. M., Johnson, S. A., et al. (1994). Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62, 741-758. doi: 10.1016/0306-4522(94)90473-1
78. Schafers, M., and Sorkin, L. (2008). Effect of cytokines on neuronal excitability. Neurosci. Lett. 437, 188-193. doi: 10.1016/j.neulet.2008.03.052
79. Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., and Besedovsky, H. O. (1998). A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 95, 7778-7783. doi: 10.1073/pnas.95.13.7778
80. Seiffert, E., Dreier, J. P., Ivens, S., Bechmann, I., Tomkins, O., Heinemann, U., et al. (2004). Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 24, 7829-7836. doi: 10.1523/JNEUROSCI.1751-04.2004
81. Sekul, E. A., Cupler, E. J., and Dalakas, M. C. (1994). Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann. Intern. Med. 121, 259-262. doi: 10.7326/0003-4819-121-4-199408150-00004
82. Serrano, G. E., Lelutiu, N., Rojas, A., Cochi, S., Shaw, R., Makinson, C. D., et al. (2011). Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 31, 14850-14860. doi: 10.1523/JNEUROSCI.3922-11.2011
83. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403. doi: 10.1038/nrneurol.2010.74
84. Snead, O. C. III, Benton, J. W., and Myers, G. J. (1983). ACTH and prednisone in childhood seizure disorders. Neurology 33, 966-970. doi: 10.1212/WNL.33.8.966
85. Sotgiu, S., Murrighile, M. R., and Constantin, G. (2010). Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurol. 10:84. doi: 10.1186/1471-2377-10-84
86. Stellwagen, D., Beattie, E. C., Seo, J. Y., and Malenka, R. C. (2005). Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 25, 3219-3228. doi: 10.1523/JNEUROSCI.4486-04.2005
87. Takao, T., Tracey, D. E., Mitchell, W. M., and De Souza, E. B. (1990). Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology 127, 3070-3078. doi: 10.1210/endo-127-6-3070
88. Toscano, C. D., Kingsley, P. J., Marnett, L. J., and Bosetti, F. (2008). NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. Neurotoxicology 29, 1114-1120. doi: 10.1016/j.neuro.2008. 08.008
89. Turrin, N. P., and Rivest, S. (2004). Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 16, 321-334. doi: 10.1016/j.nbd.2004. 03.010
90. van Gassen, K. L., de Wit, M., Koerkamp, M. J., Rensen, M. G., van Rijen, P. C., Holstege, F. C., et al. (2008). Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49, 1055-1065. doi: 10.1111/j.1528-1167.2007.01470.x
91. van Rijckevorsel-Harmant, K., Delire, M., Schmitz-Moorman, W., and Wieser, H. G. (1994). Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind/dose finding clinical study. Int. J. Clin. Lab. Res. 24, 162-126. doi: 10.1007/ BF02592447
92. van Vliet, E. A., da Costa Araujo, S., Redeker, S., van Schaik, R., Aronica, E., and Gorter, J. A. (2007). Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130, 521-534. doi: 10.1093/brain/awl318
93. Vezzani, A., and Baram, T. Z. (2007). New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Curr. 7, 45-50. doi: 10.1111/j.1535-7511.2007.00165.x
94. Vezzani, A., French, J., Bartfai, T., and Baram, T. Z. (2011a). The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31-40. doi: 10.1038/nrneu-rol.2010.178
95. Vezzani, A., Maroso, M., Balosso, S., Sanchez, M. A., and Bartfai, T. (2011b). IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyper-excitability and seizures. Brain Behav. Immun. 25, 1281-1289. doi: 10.1016/j.bbi.2011.03.018
96. Vezzani, A., and Granata, T. (2005). Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46, 1724-1743. doi: 10.1111/j.1528-1167.2005.00298.x
97. Vezzani, A., Moneta, D., Conti, M., Richichi, C., Ravizza, T., De Luigi, A., et al. (2000). Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U.S.A. 97, 11534-11539. doi: 10.1073/pnas. 190206797
98. Vianello, M., Bisson, G., Dal Maschio, M., Vassanelli, S., Girardi, S., Mucignat, C., et al. (2008). Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 41, 66-73. doi: 10.1080/08916930701619565
99. Vincent, A., and Bien, C. G. (2008). Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol. 7, 1074-1075. doi: 10.1016/S1474-4422(08)70225-4
100. Vincent, A., Irani, S. R., and Lang, B. (2010). The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr. Opin. Neurol. 23, 144-150. doi: 10.1097/WCO.0b013e32833735fe
101. Virta, M., Hurme, M., and Helminen, M. (2002). Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr. Neurol. 26, 192-195. doi: 10.1016/S0887-8994(01)00380-0
102. Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., et al. (2003). Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 8692-8700.
103. Viviani, B., Gardoni, F., and Marinovich, M. (2007). Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol. 82, 247-263. doi: 10.1016/S0074-7742(07)82013-7
104. Voutsinos-Porche, B., Koning, E., Kaplan, H., Ferrandon, A., Guenounou, M., Nehlig, A., et al. (2004). Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 17, 385-402. doi: 10.1016/j.nbd.2004.07.023
105. Wang, S., Cheng, Q., Malik, S., and Yang, J. (2000). Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 292, 497-504.
106. Watemberg, N., Greenstein, D., and Levine, A. (2006). Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J. Child Neurol. 21, 1-5. doi: 10.1177/08830738060210010201
107. Watson, R., Jiang, Y., Bermudez, I., Houlihan, L., Clover, L., McKnight, K., et al. (2004). Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63, 43-50. doi: 10.1212/01.WNL.0000132651. 66689.0F
108. Wetherington, J., Serrano, G., and Dingledine, R. (2008). Astrocytes in the epileptic brain. Neuron 58, 168-178. doi: 10.1016/j.neuron.2008.04.002
109. Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., and Worley, P. F. (1993). Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11, 371-386. doi: 10.1016/08966273(93)90192-T
110. Yamatogi, Y., Ohtsuka, Y., Ishida, T., Ichiba, N., Ishida, S., Miyake, S., et al. (1979). Treatment of the Lennox syndrome with ACTH: a clinical and electroencephalographic study. Brain Dev. 1, 267-276. doi: 10.1016/S03877604(79)80041-8
111. Yoshikawa, K., Kita, Y., Kishimoto, K., and Shimizu, T. (2006). Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2. J. Biol. Chem. 281, 14663-14669. doi: 10.1074/jbc.M511089200
112. Zeise, M. L., Espinoza, J., Morales, P., and Nalli, A. (1997). Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res. 768, 341-344. doi: 10.1016/S00068993(97)00787-7
113. Zurolo, E., Iyer, A., Maroso, M., Carbonell, C., Anink, J. J., and Ravizza, T. (2011). Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134, 1015-1032. doi: 10.1093/brain/awr032